Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Covalon Technologies Ltd (COV.VN)

Covalon Technologies Ltd (COV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 47,433
  • Shares Outstanding, K 27,418
  • Annual Sales, $ 32,816 K
  • Annual Income, $ 2,058 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.50
  • Price/Sales 1.47
  • Price/Cash Flow 21.08
  • Price/Book 1.54
  • Price/Earnings ttm 24.71
  • Earnings Per Share ttm 0.07
  • Most Recent Earnings $0.01 on 01/07/25
  • Next Earnings Date 12/11/25
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend 0.150 on 11/04/25
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.680 +2.98%
on 12/19/25
1.990 -13.07%
on 12/05/25
-0.200 (-10.36%)
since 11/24/25
3-Month
1.680 +2.98%
on 12/19/25
2.380 -27.31%
on 10/29/25
-0.420 (-19.53%)
since 09/24/25
52-Week
1.680 +2.98%
on 12/19/25
3.650 -52.60%
on 01/06/25
-1.560 (-47.42%)
since 12/24/24

Most Recent Stories

More News
Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourth quarter and full 2025 fiscal year results...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2025 financial results on Thursday, December...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on November 18, 2025 of its first ever dividend...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon Declares First Ever Special Cash Dividend

Covalon Technologies Ltd. (the “ Company” or “ Covalon” ) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wound care, vascular access, and surgical solutions,...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the Association of Pediatric Hematology/Oncology...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz has been elected Chair of the Board of...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the Association for Vascular Access (AVA) Annual...

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024

CVALF : 1.1900 (-4.03%)
COV.VN : 1.730 (+0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through...

See More

Key Turning Points

3rd Resistance Point 1.757
2nd Resistance Point 1.743
1st Resistance Point 1.737
Last Price 1.730
1st Support Level 1.717
2nd Support Level 1.703
3rd Support Level 1.697

See More

52-Week High 3.650
Fibonacci 61.8% 2.897
Fibonacci 50% 2.665
Fibonacci 38.2% 2.433
Last Price 1.730
52-Week Low 1.680

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar